Why is Hester Bios falling/rising?

As of 11-Sep, Hester Biosciences Ltd is currently priced at 2,111.00, reflecting a slight increase of 2.0 (0.09%). The stock has been gaining over the past two days, with a total return of 0.12% during this period. However, it has underperformed its sector by 0.38% today. The stock's performance over the past week shows a gain of 0.86%, while it has outperformed the benchmark Sensex, which increased by 1.03%. Despite a significant growth in net profit of 145.1% and positive results over the last five quarters, the company faces challenges such as a high Debt to EBITDA ratio of 3.49 times and poor long-term growth metrics, which may be contributing to investor caution.
Broader Market Context: In the last year, Hester Bios has underperformed the broader market, with a return of -13.05% compared to the Sensex's marginal gain of 0.03%. While the stock has shown some positive short-term movements, its long-term performance remains a concern, particularly given the low participation from domestic mutual funds, which may indicate a lack of confidence in its valuation. The stock's trading at a discount compared to its peers' historical valuations could attract some investors, but the overall market sentiment and the company's financial challenges may continue to weigh on its price movements.